Reflect Scientific, Inc (RSCF) Fair Value & Analysis
Healthcare · US · Market cap $3.9M
Reflect Scientific, Inc
RSCF · US
Fair value as of: Jul 31, 2026
From 12 valuation models · updated 10 days ago
Fair value updated Jul 31, 2026, revised from $0.0400 to $0.0422 (+5.5%) since Jun 26, 2026. Share price −2.4% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from $0.0378 (bear) to $0.0466 (bull), base $0.0422. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 60/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.
How to read this chart
60‑month range $0.0350 – $0.4300 · fair‑value band $0.0378 – $0.0466 · the $0.0400 price screens below the $0.0422 fair value. Dashed = 300-day average. As of Jul 31, 2026.
Analysis
Reflect Scientific, Inc (RSCF) currently trades at $0.0400, while our model-based Fair Value estimate is $0.0422, implying the stock looks roughly 5.5% fairly valued today. The Quality Score stands at 60/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Reflect Scientific, Inc generated revenue of $1.7M at a net margin of -1.7%. Revenue declined 2.3% year over year. It earns a return on equity of -1.4%. The balance sheet holds a net cash position of $1.8M. Fundamentals as of Jul 31, 2026
Our scenario range runs from $0.0378 (bear case) to $0.0466 (bull case); at $0.0400, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 56% below its 52-week high and 100% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at 6%, RSCF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: Multiples ($0.0500) versus Earnings-Based ($0.0200). Highest evidence: Residual Income (76).
Notify me when RSCF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 10
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines.
Full company description
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Reflect Scientific, Inc reported revenue of $1.6M in FY2025 versus $2.8M in FY2021, a compound −13.0%/yr. Reported net income was $210K in FY2025, compounding −31.3%/yr from FY2021.
Watch RSCF: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Reflect Scientific, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Reflect Scientific, Inc (RSCF) overvalued or undervalued?
What is the fair value of RSCF?
What is the quality score of RSCF?
What is the revenue of Reflect Scientific, Inc (RSCF)?
What is the net profit margin of RSCF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Reflect Scientific, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.